Table 1

Profile of most frequently prescribed antibiotics, antivirals and inmunomodulatory agents (alone or concurrently with others) during the period of study

Combination therapyNumber of patientsPercentage of patientsN (%) maleN (%) femaleMedian age (IQR) (years)
Hydroxychloroquine+lopinavir+ritonavir30728.09%191 (62)116 (38)68 (57–77)
Hydroxychloroquine+lopinavir/ritonavir+azithromycin30227.63%181 (60)121(40)69 (57–77)
Hydroxychloroquine+azithromycin26624.34%130 (49)136 (51)75 (61–84)
Azithromycin+lopinavir/ritonavir70.64%3 (43)4 (57)87 (76–91)
Azithromycin1049.52%52 (50)52 (50)87 (78–93)
Hydroxychloroquine888.05%47 (53)41 (47)79 (64–83)
Lopinavir/ritonavir191.74%12 (63)7 (37)75 (59–85)
Total 1093 100% 616(56) 477(44) 75(59–80)